Evidence map›Paper›PMID 41684379›Full record

ArticleEuropean heart journal. Case reports2026

Direct left atrial invasion by lung cancer through the pulmonary vein: a case report of a rare cause of sylent systemic embolization.

Michele Migliari, Alessandro Martis, Christian Cadeddu Dessalvi, Norma Zedda, Roberta Montisci

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michele MigliariDepartment of Medical Sciences and Public Health, University of Cagliari, Via Università, 40, Cagliari 09124, Italy.ORCID https://orcid.org/0009-0001-0908-3645
Alessandro MartisDepartment of Medical Sciences and Public Health, University of Cagliari, Via Università, 40, Cagliari 09124, Italy.
Christian Cadeddu DessalviDepartment of Medical Sciences and Public Health, University of Cagliari, Via Università, 40, Cagliari 09124, Italy.
Norma ZeddaDepartment of Medical Sciences and Public Health, University of Cagliari, Via Università, 40, Cagliari 09124, Italy.
Roberta MontisciDepartment of Medical Sciences and Public Health, University of Cagliari, Via Università, 40, Cagliari 09124, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intracardiac extension of lung cancer through the pulmonary veins is an uncommon but clinically significant manifestation, often associated with advanced-stage disease and poor prognosis. Case summary: We report the case of a 58-year-old heavy smoker who presented with rapid weight loss, asthenia, and food intolerance. Imaging revealed a large necrotic right lower lobe mass with direct invasion into the left atrium via the right inferior pulmonary vein, extending to the mitral valve. Despite the extensive cardiac involvement, the patient remained haemodynamically stable. Echocardiography showed a mobile intra-atrial mass without significant mitral obstruction but with high embolic potential. Multiple visceral infarcts were noted in the spleen and kidneys. The presence of brain metastases, bilateral adrenal involvement, and mediastinal lymphadenopathy confirmed advanced stage IV disease. The patient was deemed inoperable and referred for palliative care. Discussion: This case highlights a rare yet critical route of cardiac invasion in lung cancer. The combination of direct left atrial involvement and silent systemic embolization underscores the importance of multimodal imaging in diagnosis and risk assessment. Despite the absence of mitral obstruction, the presence of a hypermobile intracardiac mass should prompt consideration of embolic complications.

Indexed as

Cardio-oncologyCase reportLeft atrial massLung cancerMetastasis

Identifiers

PMID41684379
PMCPMC12892727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.